# The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy

> **NCT04516590** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 130 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **OTHER:** 

## Key facts

- **NCT ID:** NCT04516590
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2020-08-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516590, "The Diagnostic Value of Autoimmune Antibody Detection in Newly Onset and Chronic Epilepsy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04516590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*